COVID-19

CLINICAL DIAGNOSIS symptoms are based on, epidemiological history and positive laboratory results.

Specific laboratory diagnostics:

  • RNT detection of SARS-CoV-2 by PCR
  • Determination of specific antibodies against coronavirus in the blood - IgM, IgG
  • Determination of IgG antibodies in the blood before or after vaccination, usually after COVID-19.
  • Determination of the British strain

Antibodies, or immunoglobulins (antibody), are synthesized by the immune system in response to the entry of the virus into the body.

IgM antibodies are formed 5-7 days after the onset of the disease. The presence of these antibodies in the blood reflects the current infection. As it heals, the level of these antibodies decreases.

The test is conducted in all Referans branches and within the Medical Service at the Address.

Price: 25 Manat

COVID-19 IgG Quantitative Test

Previous, or even asymptomatic, COVID-19 or post-vaccination COVID-19 IgG quantitative testing is performed to detect immunoglobulin G (Ig G) against the spike protein on the surface of the virus in the serum.

The advantage of the test is the quantitative presentation of the result, so that the patient can recover from COVID-19 and measure the level of immune status against COVID-19. In addition, the test can be used to monitor the immune response after vaccination and to monitor the effectiveness of plasma transfusion in cured individuals.

When evaluating the clinical efficacy of the test, it was shown that the tested patients had 99.6% specificity and 99.35% sensitivity (within 15 days or more of the onset of symptoms).

This test is important in determining whether a natural or artificial specific immune response is present.

The test is conducted in all Reference branches and within the Medical Service at the Address.

Price: 48 Manat

COVID-19 nasopharyngeal smear analysis (PCR) - This method is based on the presence of genetically specific fragments of the virus in the material. The diagnosis is confirmed on the basis of a positive laboratory result of RNA SARS-CoV-2. The genetic material of the virus is detected in the human body a few days after infection by PCR. This allows us to determine both the disease and the asymptomatic course of the disease.

The test is conducted in all Reference branches and within the Medical Service at the Address.

Price: 58 Manat in normal cases (results are provided within 3-6 hours, depending on the branch), 78 AZN in urgent cases (results are provided within 1-3 hours, depending on the branch). 58 Manat in normal cases (results are provided within 3-6 hours, depending on the branch), 78 AZN in urgent cases (results are provided within 1-3 hours, depending on the branch).

  • The readiness period of COVID-19 PCR results is at least in Narimanov branch.
  • Preparation time of emergency / Express COVID-19 PCR results is 1 hour in Narimanov branch and 3 hours in other branches.
  • The test can be given 1-2 hours after a meal.
  • Each of the prophylactic tests is performed on the basis of I / O.
  • Pre-flight analysis is based on foreign passport and ticket information.
  • We would like to inform you that COVID-19 PCR analysis should be performed according to the day and time of the flight. It is enough to analyze the day before the flight.
  • Your results (references) will be valid for 72 hours from the moment of analysis.
  • Your results and references can be submitted in Azerbaijani, English and Russian, and each is confirmed by QR-CODE.

Coronaviruses are a broad family of viruses with proven pathogenic characteristics that are common in humans or animals. It is known that a number of coronaviruses can cause respiratory infections in humans, from the common cold to more serious illnesses, such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The last of the recently discovered coronaviruses, SARS-CoV-2, causes COVID-19.

A new type of coronavirus is an infectious disease caused by SARS-CoV-2. Before the outbreak in Wuhan, China in December 2019, nothing was known about the new virus or disease.

The presence of clinical symptoms of acute respiratory viral infection caused by COVID-19 is typical:

  • increase in body temperature;
  • Cough (dry or sputum) in 80% of cases;
  • shortness of breath (55%);
  • myalgia and fatigue (44%);
  • chest tightness (> 20%)

The most severe shortness of breath develops on days 6-8 of the infection. It was also determined that the first symptoms include headache (8%), bloody cough (5%), diarrhea (3%), nausea, vomiting, and palpitations. When these symptoms occur, the body temperature may not rise.

Some people infected with the virus have no symptoms or feel unwell. In most people (about 80%) the disease ends with recovery without the need for special treatment. However, in one in six cases of COVID-19 infection, severe symptoms develop with the development of respiratory failure. Older people, as well as people with diseases such as arterial hypertension, heart disease or diabetes, are more likely to have a severe infection. The mortality rate is about 2%. In case of fever, cough or respiratory failure, seek medical attention.

  • Asymptomatic
  • In mild form, but with damage to the upper respiratory tract
  • In moderate to severe form, pneumonia occurs, but without respiratory failure
  • In severe form, with respiratory failure on the background of pneumonia
  • In severe form, with multiple organ failure

A person infected with the SARS-CoV-2 virus can easily transmit the disease to others. When a person infected with the COVID-19 virus sneezes or coughs, the virus can be spread to other people through small droplets released into the air from the mouth and nasal cavity. This is caused by the droplet falling into someone else's airway. At the same time, these droplets fall on surrounding objects and surfaces. People can become infected by touching these objects or surfaces by touching their eyes, nose or mouth. For this reason, it is very important to keep a distance of more than 1 meter from the sick person and to wash your hands before touching the face. The World Health Organization (WHO) is monitoring the progress of the spread of the COVID-19 virus and will make it public as soon as the information is updated.

The incubation period is the period before infection until the onset of clinical symptoms of the disease. According to many estimates, the incubation period of SARS-CoV virus lasts from 1 to 14 days, and in most cases this period is about 5 days.

The virus is spread mainly by small droplets released into the air through the respiratory tract during coughing or sneezing. The risk of infection from a person without any symptoms is very low. On the other hand, in many people, the symptoms of COVID-19 virus are very weak. This mainly applies to the early stages of the disease. Thus, there is a risk of transmitting the COVID-19 virus from a person who does not feel sick and has a mild cough. The WHO is monitoring the progress of research on how long a sick person can infect others and will make this public as the information is updated.

  • Epidemiological history of acute respiratory infection, bronchitis, clinical signs and consequences of pneumonia:
  • travel to epidemiologically non-commercial countries and regions according to COVID-2019 during the last 14 days before the onset of symptoms
  • close contact with people who have been diagnosed with a new coronavirus infection COVID-2019 during the last 14 days and then become ill;
  • close contact with persons diagnosed with COVID-2019 during the last 14 days.